Publication | Closed Access

The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer

OncologyCancer EpidemiologyMedicineMetabolic ComorbiditiesGynecologyPharmacotherapyCancer TreatmentPublic HealthPharmacologyGynecology OncologyEndocrine-related CancerCancer MetabolismOvarian Cancer